Clinical Trial Update: Evaluation of CN-105 in Subject With Acute Supratentorial Intracerebral Hemorrhage [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating CN-105 for intracerebral hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage

Drugs mentioned

• CN-105 (CN-105)

Snippet

Sponsor: National Neuroscience Institute | Conditions: Intracerebral Hemorrhage | Phase 2 | Status: COMPLETED